YOLFTbeta
Arovella Therapeutics Ltd

Arovella Therapeutics Ltd

ALA · AU · Healthcare / Biotechnology

0.049AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.049
Open0.051
Day Range0.049 – 0.052
52-Week Range0.046 – 0.105
Volume793.84K
Market Cap56.82M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.12
50-Day Avg0.0593
200-Day Avg0.0727

About

Arovella Therapeutics Limited, a biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally. It product pipeline includes ALA-101 CD19, which is a next-generation off-the-shelf CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukaemias; ALA-105 CLDN18.2 for targeting Claudin 18.2, which is expressed in gastric cancer, gastroesophageal junction cancer, pancreatic cancer, and lung and ovarian cancer; and IL-12-TM for treating solid tumors. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is based in Preston, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Nicole van der Weerden B.Sc., BSc (Hons), MBA (MBS), Ph.D.
  • Employees0
  • HeadquartersCorporate One, Preston, VIC, Australia, 3072, Australia
  • Websitehttps://www.arovella.com

Leadership

  • Dr. Nicole van der Weerden B.Sc., BSc (Hons), MBA (MBS), Ph.D.Acting Chief Executive Officer
  • Mr. Lachie MalliaCFO & Company Secretary
  • Ms. Michelle LongSenior Administration Manager
  • Dr. Robson DossaSenior Vice President of Manufacturing & Quality
  • Dr. Michelle FergusonSenior Director of Research & Development

Financials

Income Statement

Currency: AUD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue--140.77K4.75M8.17M8.34M9.51M11.86M19.35K14.21K3.00M3.91M4.05M8.65M5.62M5.79M7.22M425.86K1.22M532.69K257.35K295.81K405.90K17.00K136.00K-
Growth (%)---+3271.18%+72.22%+2.03%+14.03%+24.70%-99.84%-26.55%+21031.19%+30.13%+3.48%+113.80%-34.96%+2.86%+24.81%-94.10%+186.26%-56.30%-51.69%+14.95%+37.22%-95.81%+700.00%-
Cost of Revenue--78.16K2.42M4.99M3.79M6.37M8.05M69.01K-2.54M3.24M3.21M6.07M5.02M4.62M5.48M185.62K199.69K200.97K222.75K207.06K3.41M42.98K107.29K117.71K
Gross Profit--62.61K2.32M3.18M4.55M3.14M3.81M-49.66K14.21K465.03K665.38K833.88K2.58M601.93K1.17M1.74M240.24K1.02M331.72K34.60K88.75K-3.00M-25.98K136.00K-117.71K
Gross Margin--44.48%48.95%38.93%54.59%33.05%32.13%-256.59%100.00%15.48%17.02%20.61%29.84%10.70%20.16%24.14%56.41%83.62%62.27%13.44%30.00%-739.07%-152.82%100.00%-
Operating Expense--1.11M3.20M4.93M4.56M4.57M6.72M2.32M2.06M3.31M2.26M2.56M4.62M4.49M3.96M3.55M6.28M3.34M4.31M3.03M7.68M6.68M10.79M11.34M11.10M
Operating Income-86.55K-750.35K-1.04M-874.90K-1.74M-6.40K-1.43M-2.91M-2.37M-2.04M-2.85M-1.60M-1.72M-2.04M-3.89M-2.79M-1.81M-6.04M-2.32M-3.98M-2.99M-7.59M-9.68M-10.81M-11.20M-11.21M
Operating Margin---741.34%-18.44%-21.34%-0.08%-15.01%-24.57%-12261.79%-14358.16%-94.75%-40.85%-42.64%-23.56%-69.08%-48.28%-25.02%-1418.55%-190.16%-746.44%-1163.67%-2566.71%-2385.02%-63595.65%-8237.35%-
EBITDA-86.55K-750.00K-876.94K-525.04K-1.33M425.27K-1.33M-8.58M-2.80M-4.42M-4.17M-4.62M-1.74M-2.02M-3.70M-2.72M-1.83M-6.44M-8.12M-3.40M-4.99M-7.87M-10.37M-10.63M-11.10M-11.10M
EBITDA Margin---622.97%-11.06%-16.33%5.10%-13.99%-72.33%-14447.63%-31066.83%-138.85%-118.28%-43.03%-23.30%-65.76%-47.02%-25.32%-1513.06%-666.39%-638.99%-1940.71%-2661.97%-2555.39%-62526.75%-8158.46%-
Net Income-79.19K-751.00K-1.06M-967.85K-1.93M-265.99K-1.77M-9.20M-3.00M-4.86M-4.51M-4.60M-1.67M-2.05M-3.37M-2.23M-1.24M-5.46M-7.80M-9.94M-5.05M-8.62M-10.18M-8.75M-7.51M-6.92M
Net Income Margin---756.50%-20.39%-23.60%-3.19%-18.65%-77.59%-15515.69%-34163.29%-150.11%-117.55%-41.22%-23.73%-59.86%-38.56%-17.15%-1281.93%-639.42%-1866.73%-1961.35%-2914.23%-2508.35%-51447.26%-5521.45%-
R&D--46.27K14.17K-------------618.94K6.68M228.78K541.55K2.60M3.98M6.74M6.52M5.87M
R&D as % of Total Revenue--32.87%0.30%-------------145.34%548.36%42.95%210.44%877.63%981.56%39619.55%4795.48%-
Interest Expense-1.00K21.34K92.95K185.15K240.52K350.00K366.68K103.93K116.83K145.07K61.92K67.51K158.64K156.20K209.56K223.45K177.03K125.06K21.27K33.29K194.72K20.67K8.63K--
Interest Expense % of Total Revenue--15.16%1.96%2.27%2.88%3.68%3.09%537.01%821.90%4.83%1.58%1.67%1.83%2.78%3.62%3.09%41.57%10.26%3.99%12.94%65.83%5.09%50.77%--

Balance Sheet

Currency: AUD2001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets6.12M3.14M4.65M16.10M14.95M16.63M21.00M16.06M16.61M11.90M13.53M9.75M10.73M20.35M22.82M19.52M20.02M16.64M16.25M6.71M10.69M9.21M5.47M13.28M21.60M15.01M
Total Liabilities3.59K146.25K885.34K2.82M3.23M3.28M6.67M5.55M7.77M3.56M2.49M2.74M4.04M4.36M3.52M2.91M3.16M5.18M2.28M2.57M1.71M1.60M1.69M2.06M1.52M857.45K
Total Equity6.11M3.00M3.77M13.27M11.72M13.35M14.33M10.26M8.84M8.35M11.03M7.01M6.69M13.95M17.27M16.61M16.85M11.46M13.98M4.14M8.98M7.62M3.78M11.23M20.08M14.15M
Cash4.33M643.00K725.58K3.77M1.83M974.83K834.87K489.04K2.90M834.29K3.56M1.59M752.62K3.99M6.25M2.45M1.77M98.13K4.31M977.47K6.72M6.07M5.18M12.71M20.88M14.35M
Total Debt3.06K66.00K425.15K1.99M2.45M2.59M4.12M3.69M4.28M1.99M1.28M701.00K1.16M1.88M1.73M1.73M1.80M2.05M53.12K85.46K79.23K144.80K144.80K---
Net Debt-4.32M-577.00K-300.42K-1.78M618.34K1.61M3.28M3.20M1.38M1.15M-2.28M-889.00K409.38K-2.12M-4.53M-718.77K32.69K1.95M-4.26M-892.01K-6.64M-5.93M-5.18M-12.71M-20.88M-14.35M

Cash Flow

Currency: AUD2002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow------------1.61M-2.61M-3.15M-1.80M-854.22K-2.55M-2.50M-2.88M-3.54M-6.27M-6.40M-6.91M-6.93M-6.91M
Investing Cash Flow-1.08M-807.63K-5.39M-810.33K-450.74K-677.62K-3.06M-104.06K-364.17K-196.76K-33.61K-907.43K-2.00M-1.27M-2.07M-1.31M676.34K-1.62M-388.42K-514.55K-566.00K95.42K-179.34K-432.11K-40.48K
Financing Cash Flow2.36M1.76M11.08M18.10K108.99K479.68K5.39M4.49M496.60K6.15M-169.16K1.66M7.84M6.79M69.00K1.48M200.00K8.10M-63.94K9.80M6.19M5.41M14.61M15.52M488.69K
Capital Expenditure626.00K169.47K1.18M454.31K450.74K146.46K2.99M84.12K1.89M508.27K33.61K911.43K2.00M1.28M1.44M1.31M908.10K1.62M388.42K514.55K566.00K2.72K129.34K412.90K39.27K
Free Cash Flow-626.00K-169.47K-1.18M-454.31K-450.74K-146.46K-2.99M-84.12K-1.89M-508.27K-33.61K-2.52M-4.62M-4.43M-3.25M-2.16M-3.46M-4.12M-3.27M-4.06M-6.83M-6.40M-7.04M-7.34M-6.95M
Dividends Paid-289.18K2.24M--2.01M128.17K-69.28K----------------
FCF to OCF-----------156.64%176.64%140.52%180.17%253.03%135.64%164.94%113.47%114.52%109.03%100.04%101.87%105.96%100.57%
Dividend Paid to FCF--170.64%-189.73%---1375.68%-4.29%--3.67%----------------

Earnings

Report DateFeb 29, 2016Sep 22, 2016Feb 27, 2017Sep 22, 2017Feb 28, 2018Aug 31, 2018Feb 28, 2019Aug 29, 2019Feb 26, 2020Aug 30, 2020Feb 26, 2021Aug 31, 2021Feb 27, 2022Aug 31, 2022Feb 23, 2023Feb 27, 2025Aug 18, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.00--0.00-
EPS Actual0.000.000.000.000.000.000.000.00-0.05-0.01-0.01-0.01-0.01-0.01-0.010.00-0.01
Surprise-----------------
Timing------------After-hoursPre-marketAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap56.82M
Enterprise Value49.72M
Trailing P/E0.00
Forward P/E0.00
Price / Sales16.24
Price / Book4.53
EPS-0.01
Book Value0.012
Revenue (TTM)3.50M
Gross Profit (TTM)3.50M
EBITDA-7.60M
Profit Margin-197.72%
Operating Margin-1874.73%
Return on Equity-40.41%
Return on Assets-26.35%
Shares Outstanding1.21B
Shares Float927.79M
Beta0.12
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 7, 202072:61
  • Nov 14, 20191:25
  • Jun 5, 201920:19
  • Jul 6, 201812:11
  • Jun 1, 2009123:112